No Data
Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Rocket Pharmaceuticals Price Target Maintained With a $38.00/Share by Canaccord Genuity
CCORF Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $38
A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $38 to $53
On Sep 18, major Wall Street analysts update their ratings for $Rocket Pharmaceuticals(RCKT.US)$, with price targets ranging from $38 to $53.Morgan Stanley analyst Michael Ulz maintains with a buy
Small U.S. Stocks Move Upward; Rocket Pharmaceuticals Leads Increases
Rocket Pharma Gains on Trial Update for Gene Therapy